IntegraMed America Inc has signed an exclusive agreement with Wichita, Kansas based Center for Reproductive Medicine (Center) to offer IntegraMed FertilityDirect products and services to the Center's patient population. Under terms of the agreement, the Center joins IntegraMed's growing national network and has access to the Company's growing inventory of patient and business services. The Center is a leading provider of advanced fertility services in the greater Wichita area.

Led by David Grainger, MD and Bruce Tjaden, DO, the Center has offices in Wichita, Kansas and provides a full spectrum of reproductive medicine services including traditional surgical infertility and a complete range of assisted reproductive technologies such as IVF, GIFT and ICSI among others. The IVF lab, directed by David Ball, PhD, was recently re-accredited by the College of American Pathologists. Board certified urologist, Jay Gilbaugh, works closely with the Center and provides surgical services for those patients requiring surgical intervention as part of their treatment for male infertility.

Under terms of the agreement, IntegraMed is committed to distribute its patient and business service offerings exclusively through the Center in the greater Wichita marketplace. Initially, the focus of distribution will be on the Company's patient-oriented offerings including the Shared Risk Refund program, IntegraMed Pharmaceutical Services, and certain Internet marketing services. In addition, the Center has the exclusive right to access a full portfolio of other products and services that the Company makes available to its growing network of Affiliated fertility centers.

With the addition of the Center in Wichita, IntegraMed has contracted with 5 new Affiliated fertility centers in 2002, dropped 2 and converted one to a full Business Services contract for a net increase of three fertility centers to the Network. IntegraMed's provider network is now comprised of 45 locations serving 17 of the top 50 markets in the United States where 80 per cent of U.S. infertility services are provided. As currently configured, this high quality provider network now effectively provides coverage for 41 per cent of the total national infertility services performed in the United States.